Wednesday, September 7, 2016

CardioCell LLC Retains Objective Capital Partners


San Diego biotech CardioCell LLC has retained Objective Capital Partners, an investment bank and mergers and acquisitions advisory firm, to help the company “manage growth,” the company said in a statement. CardioCell, founded in 2013, is currently planning a late-stage, phase 3 clinical trial for its lead program, and is primed for an “accelerated growth cycle.” READ FULL ARTICLE